Boston Scientific Corp (NYSE:BSX)
| 38.90 Delayed Data As of Sep 23 |  -0.40 / -1.02%Today’s Change | 34.98 Today|||52-Week Range 47.50 | -8.43% Year-to-Date |
Latest BSX News | Press Releases
| Here's Why You Should Retain Boston Scientific (BSX) For Now Sep 20 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 39.30 |
| Today’s open | 39.10 |
| Day’s range | 38.25 - 39.10 |
| Volume | 6,221,909 |
| Average volume (3 months) | 7,331,372 |
| Market cap | $60.4B |
Data as of 4:00pm ET, 09/23/2022
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +7.96% |
| Earnings growth (next 5 years) | +11.00% |
| Revenue growth (last year) | +19.92% |
| P/E ratio | 67.1 |
| Price/Sales | 5.12 |
| Price/Book | 3.62 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BDXBecton Dickinson and... | -3.10 | -1.31% |
| DXCMDexcom Inc | -0.24 | -0.30% |
| BAXBaxter International... | +0.06 | +0.11% |
| ZBHZimmer Biomet Holdin... | -1.83 | -1.69% |
Data as of 4:00pm ET, 09/23/2022
Financials
| Next reporting date | October 26, 2022 |
| EPS forecast (this quarter) | $0.44 |
| Annual revenue (last year) | $11.9B |
| Annual profit (last year) | $1.0B |
| Net profit margin | 8.75% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Marlborough, Massachusetts |
Forecasts
